Brett Matthew Hall insider trades: Immuneering (IMRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brett reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | IMRX | ↑ Buy | 6,035 | $4.15 | $25K | Direct | Jun 16, 2026 (1d) |
| Jan 15, 2026 | IMRX | ↑ Buy | 2,298 | $4.57 | $11K | Direct | Jan 16, 2026 (1d) |
| Jun 23, 2025 | IMRX | ↑ Buy | 13,422 | $2.58 | $35K | Direct | Jun 24, 2025 (1d) |
| Mar 20, 2024 | IMRX | ↑ Buy | 7,000 | $2.86 | $20K | Direct | Mar 21, 2024 (1d) |
| May 25, 2022 | IMRX | ↑ Buy | 2,551 | $3.92 | $10K | Direct | May 27, 2022 (2d) |
| Mar 23, 2022 | IMRX | ↑ Buy | 1,050 | $7.91 | $8K | Direct | Mar 23, 2022 (0d) |
| Aug 3, 2021 | IMRX | ↑ Buy | 1,353 | $15.00 | $20K | Direct | Aug 4, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMRX insiders
Open-market trades in the last 12 months
About Brett Matthew Hall's insider trades
Brett Matthew Hall is Chief Scientific Officer at Immuneering (IMRX). Since Aug 3, 2021, Brett has reported 7 open-market purchases worth $129K and no sales on SEC Form 4. In the last 12 months: 2 buys ($36K).
Their filings also include grants and awards (8 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.